Gain Therapeutics Growth Metrics (2020-2025) | GANX

Growth Metrics Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) -3.91M0.44M-0.47M1.03M3.95M-0.15M-0.22M
EBITDA Margin Growth (3y) -0.18M
EBITDA Margin (QoQ) -0.07M-0.39M-0.54M-2.91M4.29M-1.30M0.95M0.01M0.19M
EBIT Margin Growth (1y) -3.91M0.44M-0.47M1.03M3.95M-0.15M-0.22M
EBIT Margin Growth (3y) -0.18M
EBIT Margin (QoQ) -0.07M-0.39M-0.54M-2.91M4.29M-1.30M0.95M0.01M0.19M
EBT Margin Growth (1y) -3.77M0.45M-0.52M1.07M3.92M-0.14M-0.20M
EBT Margin Growth (3y) -0.05M
EBT Margin (QoQ) 0.03M-0.34M-0.63M-2.83M4.25M-1.31M0.96M0.02M0.19M
Enterprise Value Growth (1y) -391.46%26.32%43.84%44.53%45.40%48.12%33.21%46.18%16.60%28.94%-4.59%1.50%38.16%28.12%60.44%26.91%
Enterprise Value Growth (3y) -30.80%35.24%26.80%33.50%34.45%35.77%34.86%27.10%
Enterprise Value (QoQ) -521.04%7.36%5.08%10.00%6.89%29.39%6.25%11.40%11.53%9.11%24.46%-37.29%24.62%-33.77%28.85%13.81%12.38%26.37%-31.45%
FCF Margin Growth (1y) -4.25M0.30M0.32M0.49M4.84M-0.17M-0.22M
FCF Margin Growth (3y) 0.37M
FCF Margin (QoQ) 0.47M-0.46M-0.32M-3.94M5.02M-0.45M-0.15M0.42M0.01M
Net Margin Growth (1y) -3.78M0.45M-0.52M1.07M3.92M-0.14M-0.20M
Net Margin Growth (3y) -0.06M
Net Margin (QoQ) 0.02M-0.33M-0.63M-2.84M4.25M-1.31M0.96M0.02M0.19M
Operating Margin Growth (1y) -3.91M0.44M-0.47M1.03M3.95M-0.15M-0.22M
Operating Margin Growth (3y) -0.18M
Operating Margin (QoQ) -0.07M-0.39M-0.54M-2.91M4.29M-1.30M0.95M0.01M0.19M
Return on Assets Growth (1y) -20.00-29.00-26.00-33.00-47.00-65.00-84.00-71.00-44.00-18.008.00-35.00-68.00-67.00-82.00
Return on Assets Growth (3y) -110.00-112.00-101.00-139.00-159.00-150.00-157.00
Return on Assets (QoQ) 1.00-10.00-6.00-4.00-8.00-7.00-14.00-19.00-26.00-26.00-1.009.000.00M1.00-44.00-24.001.00-14.00
Return on Capital Employed Growth (1y) -22.00-33.00-33.00-44.00-69.00-105.00-151.00-115.00-72.00-54.0039.00-23.00-112.00-101.00-106.00
Return on Capital Employed Growth (3y) -164.00-192.00-146.00-182.00-254.00-260.00-218.00
Return on Capital Employed (QoQ) 1.00-11.00-6.00-7.00-9.00-12.00-17.00-32.00-44.00-58.0020.0010.00-26.0035.00-42.00-79.00-15.0030.00
Return on Equity Growth (1y) -23.00-35.00-34.00-46.00-70.00-113.00-176.00-142.00-88.00-46.0032.00-56.00-155.00-231.00-247.00
Return on Equity Growth (3y) -181.00-195.00-178.00-244.00-313.00-390.00-391.00
Return on Equity (QoQ) 2.00-12.00-7.00-6.00-11.00-10.00-20.00-30.00-54.00-73.0015.0025.00-12.005.00-73.00-75.00-88.00-11.00
Return on Invested Capital Growth (1y) -22.00-36.00-35.00-47.00-72.00-114.00-176.00-136.00-84.00-43.0037.00-31.00-113.00-156.00-174.00
Return on Invested Capital Growth (3y) -179.00-193.00-174.00-215.00-269.00-313.00-313.00
Return on Invested Capital (QoQ) 2.00-11.00-7.00-6.00-11.00-11.00-20.00-30.00-54.00-73.0020.0021.00-12.007.00-48.00-60.00-55.00-11.00
Return on Sales Growth (1y) -0.04M0.00M-0.01M0.01M0.04M-0.00M0.01M-0.01M-0.00M-0.03M-0.03M-0.03M
Return on Sales Growth (3y) -554.00-0.03M-0.03M-0.02M
Return on Sales (QoQ) 230.00-0.00M-0.01M-0.03M0.04M-0.01M0.01M181.000.00M-0.00M-0.00M0.00M-0.03M-290.00-614.00